Industry: Medical Devices & Consumables
Published Date: 2025-08-05
Pages: 163 Pages
Report ld: 4883038
Request Sample
Customized Report
The global DSA Contrast Media Injector market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
DSA (Digital Subtraction Angiography) contrast media injector is a medical device used in radiology procedures to inject contrast agents into a patient's bloodstream during angiographic imaging. Contrast media injectors play a critical role in enhancing the visibility of blood vessels and soft tissues in X-ray images, allowing healthcare professionals to obtain detailed and clear images for diagnosing vascular conditions, tumors, and other medical issues. These injectors are designed to deliver contrast agents at controlled rates and precise volumes to optimize imaging quality and patient safety.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
DSA Contrast Media Injector leading manufacturers including APOLLO RT, Bayer AG, Bracco, GE Healthcare, Guerbet, Medis Medical, Medtron, Nemoto, Antmed, Hengrui Medical, etc., dominate supply; the top five capture approximately % of global revenue, with APOLLO RT leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global DSA Contrast Media Injector market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the DSA Contrast Media Injector study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to DSA Contrast Media Injector: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global DSA Contrast Media Injector Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Double Head DSA Contrast Media Injector
1.2.3 Single Head DSA Contrast Media Injector
1.3 Market Segmentation by Application
1.3.1 Global DSA Contrast Media Injector Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global DSA Contrast Media Injector Revenue Estimates and Forecasts 2020-2031
2.2 Global DSA Contrast Media Injector Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global DSA Contrast Media Injector Sales Estimates and Forecasts 2020-2031
2.4 Global DSA Contrast Media Injector Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global DSA Contrast Media Injector Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global DSA Contrast Media Injector Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Double Head DSA Contrast Media Injector Market Size by Manufacturers
3.5.2 Single Head DSA Contrast Media Injector Market Size by Manufacturers
3.6 Global DSA Contrast Media Injector Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global DSA Contrast Media Injector Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global DSA Contrast Media Injector Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global DSA Contrast Media Injector Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global DSA Contrast Media Injector Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America DSA Contrast Media Injector Sales and Revenue by Type (2020-2031)
6.4 North America DSA Contrast Media Injector Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America DSA Contrast Media Injector Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe DSA Contrast Media Injector Sales and Revenue by Type (2020-2031)
7.4 Europe DSA Contrast Media Injector Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe DSA Contrast Media Injector Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific DSA Contrast Media Injector Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific DSA Contrast Media Injector Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific DSA Contrast Media Injector Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America DSA Contrast Media Injector Sales and Revenue by Type (2020-2031)
9.4 Central and South America DSA Contrast Media Injector Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America DSA Contrast Media Injector Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa DSA Contrast Media Injector Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa DSA Contrast Media Injector Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa DSA Contrast Media Injector Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 APOLLO RT
11.1.1 APOLLO RT Corporation Information
11.1.2 APOLLO RT Business Overview
11.1.3 APOLLO RT DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.1.4 APOLLO RT DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 APOLLO RT DSA Contrast Media Injector Sales by Product in 2024
11.1.6 APOLLO RT DSA Contrast Media Injector Sales by Application in 2024
11.1.7 APOLLO RT DSA Contrast Media Injector Sales by Geographic Area in 2024
11.1.8 APOLLO RT DSA Contrast Media Injector SWOT Analysis
11.1.9 APOLLO RT Recent Developments
11.2 Bayer AG
11.2.1 Bayer AG Corporation Information
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.2.4 Bayer AG DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Bayer AG DSA Contrast Media Injector Sales by Product in 2024
11.2.6 Bayer AG DSA Contrast Media Injector Sales by Application in 2024
11.2.7 Bayer AG DSA Contrast Media Injector Sales by Geographic Area in 2024
11.2.8 Bayer AG DSA Contrast Media Injector SWOT Analysis
11.2.9 Bayer AG Recent Developments
11.3 Bracco
11.3.1 Bracco Corporation Information
11.3.2 Bracco Business Overview
11.3.3 Bracco DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.3.4 Bracco DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bracco DSA Contrast Media Injector Sales by Product in 2024
11.3.6 Bracco DSA Contrast Media Injector Sales by Application in 2024
11.3.7 Bracco DSA Contrast Media Injector Sales by Geographic Area in 2024
11.3.8 Bracco DSA Contrast Media Injector SWOT Analysis
11.3.9 Bracco Recent Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Corporation Information
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.4.4 GE Healthcare DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 GE Healthcare DSA Contrast Media Injector Sales by Product in 2024
11.4.6 GE Healthcare DSA Contrast Media Injector Sales by Application in 2024
11.4.7 GE Healthcare DSA Contrast Media Injector Sales by Geographic Area in 2024
11.4.8 GE Healthcare DSA Contrast Media Injector SWOT Analysis
11.4.9 GE Healthcare Recent Developments
11.5 Guerbet
11.5.1 Guerbet Corporation Information
11.5.2 Guerbet Business Overview
11.5.3 Guerbet DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.5.4 Guerbet DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Guerbet DSA Contrast Media Injector Sales by Product in 2024
11.5.6 Guerbet DSA Contrast Media Injector Sales by Application in 2024
11.5.7 Guerbet DSA Contrast Media Injector Sales by Geographic Area in 2024
11.5.8 Guerbet DSA Contrast Media Injector SWOT Analysis
11.5.9 Guerbet Recent Developments
11.6 Medis Medical
11.6.1 Medis Medical Corporation Information
11.6.2 Medis Medical Business Overview
11.6.3 Medis Medical DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.6.4 Medis Medical DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Medis Medical Recent Developments
11.7 Medtron
11.7.1 Medtron Corporation Information
11.7.2 Medtron Business Overview
11.7.3 Medtron DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.7.4 Medtron DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Medtron Recent Developments
11.8 Nemoto
11.8.1 Nemoto Corporation Information
11.8.2 Nemoto Business Overview
11.8.3 Nemoto DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.8.4 Nemoto DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Nemoto Recent Developments
11.9 Antmed
11.9.1 Antmed Corporation Information
11.9.2 Antmed Business Overview
11.9.3 Antmed DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.9.4 Antmed DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Antmed Recent Developments
11.10 Hengrui Medical
11.10.1 Hengrui Medical Corporation Information
11.10.2 Hengrui Medical Business Overview
11.10.3 Hengrui Medical DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.10.4 Hengrui Medical DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Hengrui Medical Recent Developments
11.11 SINO MDT
11.11.1 SINO MDT Corporation Information
11.11.2 SINO MDT Business Overview
11.11.3 SINO MDT DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.11.4 SINO MDT DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 SINO MDT Recent Developments
11.12 Dongguan Yixing Medical Technology
11.12.1 Dongguan Yixing Medical Technology Corporation Information
11.12.2 Dongguan Yixing Medical Technology Business Overview
11.12.3 Dongguan Yixing Medical Technology DSA Contrast Media Injector Product Models, Descriptions and Specifications
11.12.4 Dongguan Yixing Medical Technology DSA Contrast Media Injector Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Dongguan Yixing Medical Technology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 DSA Contrast Media Injector Industry Chain
12.2 DSA Contrast Media Injector Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 DSA Contrast Media Injector Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 DSA Contrast Media Injector Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 DSA Contrast Media Injector Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global DSA Contrast Media Injector Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global DSA Contrast Media Injector market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 161
USD 4900.00
(Single User License)
The global DSA Contrast Media Injector market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 98
USD 4250.00
(Single User License)
The global market for DSA Contrast Media Injector was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 112
USD 3950.00
(Single User License)
The global DSA Contrast Media Injector market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 122
USD 2900.00
(Single User License)
The global DSA Contrast Media Injector market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 92
USD 4250.00
(Single User License)
The global market for DSA Contrast Media Injector was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 117
USD 3950.00
(Single User License)
The global market for DSA Contrast Media Injector was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 88
USD 2900.00
(Single User License)
DSA (Digital Subtraction Angiography) contrast media injector is a medical device used in radiology procedures to inject contrast agents into a patient's bloodstream during angiographic imaging. Contrast media injectors play a critical role in enhancing the visibility of blood vessels and soft tissues in X-ray images, allowing healthcare professionals to obtain detailed and clear images for diagnosing vascular conditions, tumors, and other medical issues. These injectors are designed to deliver contrast agents at controlled rates and precise volumes to optimize imaging quality and patient safety.
Published Date: 2024-06-15
Pages: 124
USD 4350.00
(Single User License)
DSA (Digital Subtraction Angiography) contrast media injector is a medical device used in radiology procedures to inject contrast agents into a patient's bloodstream during angiographic imaging. Contrast media injectors play a critical role in enhancing the visibility of blood vessels and soft tissues in X-ray images, allowing healthcare professionals to obtain detailed and clear images for diagnosing vascular conditions, tumors, and other medical issues. These injectors are designed to deliver contrast agents at controlled rates and precise volumes to optimize imaging quality and patient safety.
Published Date: 2024-06-15
Pages: 90
USD 2900.00
(Single User License)
DSA (Digital Subtraction Angiography) contrast media injector is a medical device used in radiology procedures to inject contrast agents into a patient's bloodstream during angiographic imaging. Contrast media injectors play a critical role in enhancing the visibility of blood vessels and soft tissues in X-ray images, allowing healthcare professionals to obtain detailed and clear images for diagnosing vascular conditions, tumors, and other medical issues. These injectors are designed to deliver contrast agents at controlled rates and precise volumes to optimize imaging quality and patient safety.
Published Date: 2024-06-15
Pages: 163
USD 4900.00
(Single User License)
The global DSA Contrast Media Injector market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 161
The global DSA Contrast Media Injector market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 98
The global market for DSA Contrast Media Injector was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 112
The global DSA Contrast Media Injector market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 122
The global DSA Contrast Media Injector market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 92
The global market for DSA Contrast Media Injector was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 117
The global market for DSA Contrast Media Injector was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 88
DSA (Digital Subtraction Angiography) contrast media injector is a medical device used in radiology procedures to inject contrast agents into a patient's bloodstream during angiographic imaging. Contrast media injectors play a critical role in enhancing the visibility of blood vessels and soft tissues in X-ray images, allowing healthcare professionals to obtain detailed and clear images for diagnosing vascular conditions, tumors, and other medical issues. These injectors are designed to deliver contrast agents at controlled rates and precise volumes to optimize imaging quality and patient safety.
Published: 2024-06-15
Pages: 124
DSA (Digital Subtraction Angiography) contrast media injector is a medical device used in radiology procedures to inject contrast agents into a patient's bloodstream during angiographic imaging. Contrast media injectors play a critical role in enhancing the visibility of blood vessels and soft tissues in X-ray images, allowing healthcare professionals to obtain detailed and clear images for diagnosing vascular conditions, tumors, and other medical issues. These injectors are designed to deliver contrast agents at controlled rates and precise volumes to optimize imaging quality and patient safety.
Published: 2024-06-15
Pages: 90
DSA (Digital Subtraction Angiography) contrast media injector is a medical device used in radiology procedures to inject contrast agents into a patient's bloodstream during angiographic imaging. Contrast media injectors play a critical role in enhancing the visibility of blood vessels and soft tissues in X-ray images, allowing healthcare professionals to obtain detailed and clear images for diagnosing vascular conditions, tumors, and other medical issues. These injectors are designed to deliver contrast agents at controlled rates and precise volumes to optimize imaging quality and patient safety.
Published: 2024-06-15
Pages: 163
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now